Judith M Versluis Selected Research

Immunotherapy

12/2022	Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis.
11/2022	Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome.
11/2022	Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study.
1/2022	Clinical Models to Define Response and Survival With Anti-PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma.
1/2021	Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma.
1/2020	Learning from clinical trials of neoadjuvant checkpoint blockade.
1/2020	Rationalizing the pathway to personalized neoadjuvant immunotherapy: the Lombard Street Approach.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Judith M Versluis Research Topics

Disease

15	Melanoma (Melanoma, Malignant) 04/2024 - 01/2020
8	Neoplasms (Cancer) 04/2024 - 01/2020
2	Disease Progression 11/2023 - 01/2023
2	Glioma (Gliomas) 12/2022 - 11/2022
2	Encephalitis (Encephalitis, Rasmussen) 12/2022 - 11/2022
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2021
2	Lymphatic Metastasis 01/2022 - 01/2021
1	Leukocytosis (Pleocytosis) 11/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2022

Drug/Important Bio-Agent (IBA)

6	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2021
6	IpilimumabIBA 01/2023 - 01/2021
5	NivolumabIBA 01/2023 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2022
2	pembrolizumabIBA 01/2023 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2022
2	Leucine (L-Leucine)FDA Link 12/2022 - 11/2022
2	AntibodiesIBA 11/2022 - 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 04/2024
1	RNA (Ribonucleic Acid)IBA 04/2024
1	B7-H1 AntigenIBA 01/2023
1	Histone Deacetylase InhibitorsIBA 01/2023
1	domatinostatIBA 01/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	cyclopropapyrroloindoleIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022

Therapy/Procedure

9	Therapeutics 04/2024 - 01/2020
7	Immunotherapy 12/2022 - 01/2020
4	Neoadjuvant Therapy 01/2023 - 01/2020
2	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 01/2021
1	Salvage Therapy 11/2023
1	Secondary Prevention 08/2022
1	Radiotherapy 01/2022